Fishman Jay A LTD Pfizer Inc Transaction History

Fishman Jay A LTD

$1.01 Billion
Q3 2024

A detailed history of Fishman Jay A LTD transactions in Pfizer Inc stock. As of the latest transaction made, Fishman Jay A LTD holds 298,304 shares of PFE stock, worth $7.94 Million. This represents 0.86% of its overall portfolio holdings.

Number of Shares

298,304

Previous 295,304 1.02%

Holding current value

$7.94 Million

Previous $8.26 Million 4.48%

% of portfolio

0.86%

Previous 0.87%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 30, 2024	BUY	$27.7 - $31.39 $83,100 - $94,170	3,000 Added 1.02%	298,304 $8.63 Million
Q2 2024 Aug 05, 2024	BUY	$25.26 - $29.6 $7.27 Million - $8.52 Million	287,914 Added 3895.99%	295,304 $8.26 Million
Q2 2024 Jul 31, 2024	SELL	$25.26 - $29.6 $7.25 Million - $8.49 Million	-286,897 Reduced 97.49%	7,390 $206,000
Q1 2024 Apr 23, 2024	BUY	$25.89 - $29.73 $92,038 - $105,690	3,555 Added 1.22%	294,287 $8.17 Million
Q4 2023 Jan 24, 2024	BUY	$26.13 - $33.94 $14,371 - $18,667	550 Added 0.19%	290,732 $8.37 Million
Q3 2023 Nov 13, 2023	SELL	$32.09 - $37.51 $701,134 - $819,555	-21,849 Reduced 7.0%	290,182 $9.63 Million
Q2 2023 Aug 15, 2023	SELL	$36.12 - $41.79 $1.9 Million - $2.2 Million	-52,620 Reduced 14.43%	312,031 $11.4 Million
Q1 2023 May 09, 2023	SELL	$39.39 - $51.28 $1.02 Million - $1.33 Million	-25,853 Reduced 6.62%	364,651 $14.9 Million
Q4 2022 Feb 13, 2023	SELL	$41.75 - $54.5 $442,174 - $577,209	-10,591 Reduced 2.64%	390,504 $20 Million
Q3 2022 Oct 26, 2022	BUY	$43.76 - $53.42 $122,134 - $149,095	2,791 Added 0.7%	401,095 $17.6 Million
Q2 2022 Aug 09, 2022	SELL	$46.53 - $55.17 $434,497 - $515,177	-9,338 Reduced 2.29%	398,304 $20.9 Million
Q1 2022 May 10, 2022	SELL	$45.75 - $56.69 $375,150 - $464,858	-8,200 Reduced 1.97%	407,642 $21.1 Million
Q4 2021 Feb 14, 2022	BUY	$41.32 - $61.25 $3.64 Million - $5.39 Million	88,065 Added 26.87%	415,842 $24.6 Million
Q3 2021 Nov 08, 2021	SELL	$39.25 - $50.42 $4.3 Million - $5.52 Million	-109,536 Reduced 25.05%	327,777 $14.1 Million
Q2 2021 Aug 09, 2021	SELL	$35.91 - $40.68 $940,051 - $1.06 Million	-26,178 Reduced 5.65%	437,313 $17.1 Million
Q1 2021 May 03, 2021	SELL	$33.49 - $37.77 $1.2 Million - $1.36 Million	-35,902 Reduced 7.19%	463,491 $16.8 Million
Q2 2020 Aug 10, 2020	SELL	$30.12 - $36.54 $371,229 - $450,355	-12,325 Reduced 2.41%	499,393 $15.5 Million
Q1 2020 May 13, 2020	SELL	$27.03 - $38.62 $4.04 Million - $5.78 Million	-149,594 Reduced 22.62%	511,718 $15.8 Million
Q1 2020 May 12, 2020	BUY	$27.03 - $38.62 $2.76 Million - $3.95 Million	102,257 Added 18.29%	661,312 $20.5 Million
Q4 2019 Feb 04, 2020	SELL	$32.92 - $37.36 $1.22 Million - $1.39 Million	-37,090 Reduced 6.22%	559,055 $20.8 Million
Q3 2019 Nov 05, 2019	SELL	$32.49 - $42.13 $754,417 - $978,258	-23,220 Reduced 3.75%	596,145 $20.3 Million
Q2 2019 Aug 06, 2019	SELL	$36.98 - $41.52 $1.55 Million - $1.74 Million	-41,947 Reduced 6.34%	619,365 $0
Q1 2019 May 01, 2019	SELL	$37.5 - $41.2 $155,625 - $170,980	-4,150 Reduced 0.62%	661,312 $0
Q4 2018 Feb 05, 2019	SELL	$38.47 - $43.86 $287,755 - $328,072	-7,480 Reduced 1.11%	665,462 $27.6 Million
Q3 2018 Oct 31, 2018	SELL	$34.47 - $41.81 $137,880 - $167,240	-4,000 Reduced 0.59%	672,942 $0
Q2 2018 Aug 06, 2018	SELL	$32.98 - $35.16 $556,570 - $593,360	-16,876 Reduced 2.43%	676,942 $0
Q1 2018 May 08, 2018	SELL	$31.91 - $37.02 $369,198 - $428,321	-11,570 Reduced 1.64%	693,818 $0
Q4 2017 Feb 05, 2018	SELL	$33.26 - $35.29 $137,097 - $145,465	-4,122 Reduced 0.58%	705,388 $0
Q3 2017 Oct 31, 2017	BUY	$31.0 - $34.15 $22 Million - $24.2 Million	709,510	709,510 $0

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $149B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fishman Jay A LTD, based on Form 13F filings with the SEC.

News

Stay updated on Fishman Jay A LTD with notifications on news.

Account